Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Two new studies reveal how US scientists managed to uncover the detailed structure of a protein that plays a key role in HIV infection. The findings offer the kind of in-depth understanding that has been missing in the development of successful vaccines against the AIDS virus.
Using protein engineering and two different cutting-edge structural biology imaging techniques, collaborating teams from The Scripps Research Institute (TSRI) and Weill Cornell Medical College have revealed a detailed atomic structure of the HIV envelope trimer known as Env.
The new discovery is documented in two studies, both published online in Science this week.
None of the HIV vaccines tested so far has come close to giving enough protection, a failure that is largely due to the challenges posed by Env.
Env is a three-part protein (a trimer) found on the surface of HIV that is critical to understanding how the virus gets into human cells to cause infection.
Env has evolved highly effective ways of avoiding attack by the immune system. For instance, it frequently mutates its outermost regions, and it also coats its surfaces with very slippery sugar molecules called glycans.
The more scientists know about Env and its structure, the higher the chances of developing successful vaccines.
It has been difficult to get atomic-level resolution images of the Env protein because its structure is complex and delicate - but now new techniques have now made this possible.
First, to capture the image, the teams engineered a more stable version of the protein, as one of the senior authors Andrew Ward, an assistant professor in TSRI's Department of Integrative Structural and Computational Biology, explains:
"It tends to fall apart, for example, even when it's on the surface of the virus, so to study it we have to engineer it to be more stable."
Then, having stabilized the Env trimer, using cryo-electron microscopy and X-ray crystallography, the scientists were able to discover its structure and also how it assembles and engages with HIV antibodies.
One aspect of the discovery that will be of great help to vaccine developers is knowing the precise details of the sites where HIV antibodies can bind to the virus - so they can mimic these viral "epitopes" with the vaccine.
Another senior author, Ian A. Wilson, the Hansen Professor of Structural Biology at TSRI, says:
"Most of the prior structural studies of this envelope complex focused on individual subunits, but we've needed the structure of the full complex to properly define the sites of vulnerability that could be targeted, for example with a vaccine."
Funds from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, helped finance the studies.
In another recently published study, researchers from the University of Florida and the University of California, San Francisco, describe how cats may be key to HIV vaccine. They found that blood from patients infected with HIV showed an immune response against a feline AIDS virus protein.
Written by Catharine Paddock PhD
Copyright: Medical News Today
Not to be reproduced without the permission of Medical News Today.
Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer; Dmitry Lyumkis, Jean-Philippe Julien, Natalia de Val, Albert Cupo, Clinton S. Potter, Per-Johan Klasse, Dennis R. Burton, Rogier W. Sanders, John P. Moore, Bridget Carragher, Ian A. Wilson, and Andrew B. Ward; Science Published online 31 October 2013; DOI: 10.1126/science.1245627; Abstract.
Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer; Jean-Philippe Julien, Albert Cupo, Devin Sok, Robyn L. Stanfield, Dmitry Lyumkis, Marc C. Deller, Per-Johan Klasse, Dennis R. Burton, Rogier W. Sanders, John P. Moore, Andrew B. Ward, and Ian A. Wilson; Science Published online 31 October 2013; DOI: 10.1126/science.1245625; Abstract.
Visit our HIV / AIDS category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Paddock, Catharine. "HIV vaccine clue found in structure of key infection protein." Medical News Today. MediLexicon, Intl., 1 Nov. 2013. Web.
5 Dec. 2013. <http://www.medicalnewstoday.com/articles/268227>
Paddock, C. (2013, November 1). "HIV vaccine clue found in structure of key infection protein." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/articles/268227.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.